ANANDRON

This brand name is authorized in Australia, Canada, France, Netherlands.

Active ingredients

The drug ANANDRON contains one active pharmaceutical ingredient (API):

1
UNII 51G6I8B902 - NILUTAMIDE
 
Read more about Nilutamide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L02BB02 Nilutamide L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BB Anti-androgens
Discover more medicines within L02BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 8131Y
CA Health Products and Food Branch 02221861
FR Base de données publique des médicaments 67541333, 69060099
NL Z-Index G-Standaard, PRK 45063

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈